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Edited by Hans-Dieter KlenkAbstract Common human adenovirus (Ad) vectors are derived
from serotype 2 or 5, which use the coxsackie-adenovirus recep-
tor (CAR) as their primary cell receptor. We investigated the
receptor usage of mouse adenovirus type 1 (MAV-1), which
in vivo is characterized by a pronounced endothelial cell tropism.
Alignment of the ﬁber knob sequences of MAV-1 and those of
CAR-using adenoviruses, revealed that amino acid residues, crit-
ical for interaction with CAR, are not conserved in the MAV-1
ﬁber knob. Attachment of MAV-1 to Chinese hamster ovary
(CHO) cells was not increased by stable transfection with mouse
CAR, whereas the binding eﬃciency of Ad2 was 20-fold higher in
the mouse CAR-transfectant compared to the wild type cells.
Also, puriﬁed ﬁber knob of Ad5, which is interchangeable with
the Ad2 ﬁber knob, did not compete with MAV-1 for receptor
binding, indicating that MAV-1 binds to a receptor diﬀerent
from CAR. These results support further exploration of an
MAV-1-derived vector as a potential vehicle for gene delivery
to cell types which are not eﬃciently transduced by human ade-
novirus vectors.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Attachment to a susceptible cell is the ﬁrst step in adenovirus
infection and is mediated by the high-aﬃnity binding of the
adenoviral ﬁber knob to a primary cellular attachment recep-
tor. Species from human adenovirus subgroups A, C, D, E
and F, but not subgroup B, use the coxsackie-adenovirus
receptor (CAR) for their primary attachment [1–3]. CAR is a
46 kDa transmembrane protein with two immunoglobulin-like
extracellular domains and a long cytoplasmic domain that
plays a role in cell adhesion [4,5]. In addition to CAR, several
other cell surface molecules have been implicated in the attach-
ment of human adenoviruses, including the a2 domain of the
MHC-I heavy chain, sialic acid, CD46, CD80/CD86 and hep-
aran sulfate glucosaminoglycans [6]. After the initial interac-
tion between the adenovirus ﬁber knob domain and its
primary attachment receptor, internalization of the virus*Corresponding author. Fax: +32 16 337340.
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doi:10.1016/j.febslet.2006.06.027particle is mediated by the association of the penton base with
secondary cell receptors, such as av integrins [7].
The CAR-using human serotypes Ad2 and Ad5 have been
studied extensively and are most frequently adapted as vectors
for gene therapy applications. Unfortunately, their clinical eﬃ-
cacy is limited by the relatively broad tissue expression of CAR,
resulting in non-speciﬁc tissue distribution of the vector, and
the low CAR expression on speciﬁc target cells, such as tumor
cells, skeletal and smooth muscle cells and endothelial cells [8].
Moreover, pre-existing immunity to human adenoviruses re-
sults in rapid clearance of the vectors after administration [9].
To overcome these constraints, non-human adenoviruses have
been proposed as alternative gene delivery vectors [10,11]. In
this regard, we explored the receptor usage of mouse adenovi-
rus type 1 (MAV-1). In vivo, MAV-1 displays a broad tissue dis-
tribution, marked by a striking endothelial cell tropism [12–14].
Replication of MAV-1 is speciﬁc to mouse cells and the virus
does not replicate in human cells. However, MAV-1 was shown
to be capable of infecting, and expressing in, human endothelial
cells [15]. Using mouse CAR-transfected Chinese hamster
ovary (CHO) cells and competition assays with the puriﬁed
ﬁber knob of Ad5, we have demonstrated that the primary
attachment of MAV-1 to target cells is independent of CAR.
Therefore, MAV-1-based vectors may be useful for human
gene delivery to target cells with low expression of CAR.2. Materials and methods
2.1. Cells and viruses
The C3H/3T3 mouse embryonic ﬁbroblast cell line, originally estab-
lished by Billiau et al. [16], was subcultivated in Dulbecco’s minimal
essential medium (DMEM) supplemented with 0.075% bicarbonate,
1 mM sodium pyruvate and 10% heat-inactivated newborn calf serum.
Human lung carcinoma A549 cells and Chinese hamster ovary CHO-
K1 cells [both obtained from American Type Culture Collection
(ATCC)] were subcultivated as recommended by the supplier. Mouse
adenovirus type 1 strain FL (MAV-1) was obtained from ATCC. The
human adenovirus type 2 (Ad2; subgroup C) and type 3 (Ad3; sub-
group B) strains were clinical isolates serotyped by sequence analysis.
Virus stocks were prepared in C3H/3T3 cells infected with MAV-1,
or A549 cells infected with Ad2 or Ad3, and puriﬁed chromatographi-
cally by the Vivapure AdenoPACKe puriﬁcation kit (Vivascience)
[14]. The titers of the virus stocks, determined by real-time PCR (see be-
low), were 1010, 1012 and 1010 viral particles per ml for MAV-1,
Ad2 and Ad3, respectively. All cell lines and virus stocks were free of
Mycoplasma contamination, as determined by PCR analysis.2.2. Establishment of the CHO-mCAR-EGFP cell line
RNA was extracted from heart tissue of a 10-day-old mouse, using
theRNeasyMiniKit (Qiagen). After cDNA synthesis, mouse coxsackie-
adenovirus receptor (mCAR) cDNA was ampliﬁed with the Expandblished by Elsevier B.V. All rights reserved.
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GAATTCATTACCTGCAAGCCACGAC-30 and reverse: 5 0-AAAGT-
CGACCATACCACTGTAATGCCATCGG-30) contained an EcoRI
and SalI site (underlined) and extra bases (bold) to allow in-frame inser-
tion in the EGFP-N1 vector (Clontech). After ligation in the EGFP-N1
vector and transformation in E. coli, one clone containing the exact
mCAR cDNA sequence (GenBankAccession No. NM_009988) was se-
lected. The plasmid DNA was transfected into CHO-K1 cells with Fu-
gene 6 reagent (Roche) using the manufacturer’s instructions. After 96 h
incubation at 37 C, cells were subcultivated for three weeks in the pres-
ence of 1 mg per ml geneticin. Cells were cloned by limiting dilution in
96-well trays, expanded, and examined (without prior ﬁxation) for
expression of the mCAR-EGFP fusion protein by ﬂuorescence micros-
copy, as described by Daelemans et al. [17]. One CHO-mCAR-EGFP
transfectant showing high and homogenous membrane expression
was selected and subsequently used for all virus binding studies.2.3. Determination of mCAR mRNA levels
Approximately 5 · 106 cells were used for RNA extraction, using the
RNeasy Mini Kit. First-strand cDNA synthesis was carried out using
oligo(dT)15 primer. mCAR cDNA was ampliﬁed with the following
primers: 5 0-AAAGAATTCATTACCTGCAAGCCACGAC-3 0 and
5 0-GGGCTTTCTTCACTTTGCAC-3 0, yielding a 410-bp amplicon.
Determination of b-actin expression was included to normalize the
results for the diﬀerent cell lines. The forward primer (5 0-TCAA-
CACCCCAGCCATGTA-3 0) and reverse primer (5 0-CAGGTCCA-
GACGCAGGAT-3 0) were chosen to amplify a 161-bp fragment
within the conserved b-actin sequence. PCR products were size-
separated on a 2% agarose gel and visualized under UV illumination
after ethidium bromide staining.
In order to quantify mCAR mRNA expression, cDNA samples
were analyzed by real-time PCR, using the qPCR MasterMix for
SYBR green I (Eurogentec). Forward (5 0-GTCGGACATTGGC-
ACTTACC-3 0) and reverse (5 0-GGGCTTTCTTCACTTTGCAC)
primers were chosen to amplify a 41-bp fragment within the mCAR
cDNA sequence. The b-actin level of each cDNA sample was mea-
sured in parallel (using the b-actin primers described above). Real-
time PCR analysis was performed in an ABI Prism 7000 apparatus
(Applied Biosystems), and consisted of 10 min initial denaturation at
95 C, followed by 40 thermal cycles of 15 sec at 95 C and 120 sec
at 60 C. A dissociation proﬁle was taken at the end to conﬁrm the
speciﬁcity of the PCR ampliﬁcation. The following standard curves
were included: a series of known amounts of the EGFP-N1-mCAR
vector construct (R2 > 0.99 within the range of 4 · 102–4 · 109 copies
per reaction) and a dilution series of a DNA-extract of an exact
determined amount of peripheral blood lymphocytes to obtain a
standard curve for b-actin (R2 > 0.98 within the range 2 · 102–
2 · 105 b-actin DNA copies per reaction). These standard curves
were used to convert the respective cycle threshold (Ct) values into
the number of mCAR cDNA copies per copy b-actin cDNA. All
samples were analyzed in duplo.2.4. Preparation of adenovirus ﬁber knob proteins
Recombinant E. coli (strain M15) encoding the His-tagged ﬁber
knob of Ad5 (Ad5F) was kindly provided by Dr. P. Pring-A˚kerblom
(when at the Institut fu¨r Virologie und Seuchenhygiene, Hannover).
Expression and puriﬁcation was performed as described in the QIA
expressioniste (Qiagen). Puriﬁed Ad5F was dialyzed against 50 mM
Tris–HCl buﬀer, pH 8, containing 154 mM NaCl and 20% glycerol.
Trimerization of the recombinant ﬁber knob protein was veriﬁed
by SDS–PAGE analysis of unboiled versus boiled ﬁber samples, fol-
lowed by Coomassie blue staining and Western blot analysis using
the 6·His mAB/HRP conjugate (BD Biosciences) directed against
the 6·His tag.2.5. Binding and competition assays
All assays were performed using conﬂuent cells, seeded in 96-well
plates. Each condition was done at least in duplicate and all experi-
ments were repeated two to three times.
Binding assays were performed at 4 C with CHO-mCAR-EGFP
and CHO-K1 cells, and C3H/3T3 and A549 cells as control cells. To
block non-speciﬁc binding, cells were pre-incubated with minimumessential medium (MEM) supplemented with 2% fetal calf serum
(FCS) during 15 min. The medium was removed and 50 ll of virus
was added, diluted in MEM plus 2% FCS, to obtain a multiplicity
of infection of 104 virus particles per cell. After 60 min on ice with
gentle agitation, unbound virus was removed by three rinses of PBS
plus 2% FCS. To exactly determine the total amount of virus particles
added, a sample was included from which virus was not removed from
the cells. Uninfected controls received medium instead of virus, and
were further treated in the same way as test samples. Cells were subse-
quently subjected to lysis and DNA extraction, using the QIAamp
DNA Mini Kit (Qiagen).
Competition assays with C3H/3T3 and A549 cells were performed
as described for the binding assay, but before virus was added, cells
were pre-incubated for 45 min with 50 ll of Ad5F, diluted in MEM
plus 2% FCS. Control samples were included in which no Ad5F
was added.2.6. Quantiﬁcation of virus particles
To determine the number of virus particles, DNA extracts were sub-
jected to SYBR green I based real-time PCR analysis, performed as
described above. Forward and reverse primer, derived from GenBank
sequences, were chosen to amplify a 137-bp fragment within the
conserved adenovirus hexon DNA sequence (forward: 5 0-CGCT-
GGACATGACTTTTGAG-3 0 and reverse: 5 0-GAACGGTGTGCG-
CAGGTA-3 0) or a 167-bp fragment within the MAV-1 hexon DNA
sequence (forward: 5 0-GGCCAACACTACCGACACTT-3 0 and
reverse: 5 0-TTTTGTCCTGTGGCATTTGA-3 0). The thermal proﬁle
consisted of 10 min initial denaturation at 95 C, followed by 40
thermal cycles of 15 sec at 95 C and 90 sec at 60 C. A standard curve
(R2 > 0.98 within the range of 103–108 copies per reaction) was obtained
by ampliﬁcation of known amounts of a pGEM T-vector in which a
691-bp fragment of adenovirus hexon DNA or a 743-bp fragment of
MAV-1 hexon DNA was inserted using common cloning procedures.
These standard curves were used to convert the Ct values for the ex-
tracts into the absolute number of human adenovirus DNA or MAV-
1 DNA copies, respectively. All samples were analyzed in duplo.
2.7. Statistical analysis
Data were compared by 2-tailed Student’s t test for statistical signif-
icance. P < 0.05 was considered signiﬁcant.3. Results and discussion
3.1. Comparative sequence analysis of the ﬁber knobs of MAV-1
and other adenoviruses
Site-directed mutagenesis and crystallographic studies with
the ﬁber knob of Ad5 and Ad12 pointed to several amino
acid residues critical for binding to human CAR. The major-
ity of these amino acids are located within the AB loop of the
knob domain, which is well conserved in CAR-binding
human adenoviruses, but not in species B human adenovi-
ruses [18–20]. By comparing the ﬁber knob sequences of
MAV-1 and CAR-binding human adenoviruses (Fig. 1), we
found that the residues critical for interaction with CAR
are not conserved in the MAV-1 ﬁber knob, and that the
amino acid identity of the MAV-1 ﬁber knob compared to
its Ad5 counterpart is only 17% (as determined with the
AlignX module, PAM250 matrix from the Vector NTI
Advancee software, Invitrogen). Moreover, receptor–ﬁber
interactions are complex, since the length and ﬂexibility of
the ﬁber shaft also inﬂuence knob–CAR interactions [21].
The ﬁber shaft of MAV-1 contains a slightly diﬀerent organi-
zation compared to that of human adenoviruses [22]. Given
the diﬃculty to predict receptor usage from alignments on
distant species, we initiated this study to determine whether
binding of MAV-1 is mediated by CAR.
Fig. 1. Alignment of the ﬁber knob sequence of MAV-1 [Accession No. NP_015554 (NCBI/Entrez protein database)] with that from CAR-binding
[Ad12, Accession No. CAA51900; Ad5, P11818; Ad2, CAC67295] and non-CAR binding [Ad3, CAA26029] human adenoviruses. Identical residues
are in red font highlighted in yellow; similar amino acids are highlighted in green and marked in blue are conserved residues. Residues in the Ad5
ﬁber knob, which are identiﬁed as interacting with CAR by mutagenesis studies according to Roelvink et al. [20] and Kirby et al. [19] are boxed in
black. Boxed in orange are key residues in the Ad12 ﬁber knob that contact CAR in the Ad12 ﬁber knob-CAR crystal structure [18].
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We ﬁrst constructed a cell line expressing high levels of
CAR. Since the murine (mCAR) and human CAR (hCAR)
homologues are 83% identical, with >90% amino acid iden-
tity within the extracellular domain, and mCAR has been
shown to mediate ﬁber-dependent attachment of subgroup
C adenoviruses [23,24], we found it more pertinent to check
whether mCAR could function as an attachment receptorFig. 2. Fluorescence microscopy of the CHO-mCAR-EGFP transfec-
ted cell line. CHO-K1 cells, stably transfected with mCAR-EGFP,
were directly examined by ﬂuorescence microscopy. The mCAR-
EGFP fusion protein is mainly localized to the membrane, with a
strong ﬂuorescence at the intercellular junctions. This pattern is
identical to the one observed by Cohen et al. [4].for MAV-1. Therefore, a stable CHO transfectant cell line
with high and homogenous membrane expression of
mCAR-EGFP was developed and selected, based on the
expression pattern of the mCAR-EGFP fusion protein. Fluo-
rescence microscopy on unstained cells (Fig. 2) revealed that
the mCAR-EGFP fusion protein mainly localizes to the
membrane, with a strong ﬂuorescence at the intercellular
junctions. This pattern is identical to the one observed by Co-
hen et al. with hCAR-transfected CHO cells [4], implicating
that the EGFP-tag in the mCAR-EGFP fusion protein does
not inﬂuence correct posttranslational processing and mem-
brane localization. The CHO-mCAR-EGFP transfectant
was found to be fully stable when subcultivated in the pres-
ence of the selection marker geneticin, since the cell line
has been kept for >90 passages without any change in ﬂuo-
rescence pattern.
The expression level of mCAR mRNA in the CHO-K1 and
CHO-mCAR-EGFP transfected cell lines was determined by
reverse transcriptase PCR (Fig. 3a). As expected, no signal
for mCAR mRNA was detected in CHO-K1 cells, which
were used as a negative control, whereas CHO-mCAR-EGFP
cells were strongly positive for mCAR. Although murine
NIH/3T3 cells were earlier described to be CAR-deﬁcient
[25,24], we detected a low signal for mCAR mRNA in the
C3H/3T3 cell line, a mouse embryonic ﬁbroblast cell line that
is permissive for MAV-1 replication [14]. This observation
was conﬁrmed by real-time PCR analysis: the level of mCAR
mRNA was about 275 times higher in CHO-mCAR-EGFP
cells compared to C3H/3T3 cells (Fig. 3b). However, the
low level of mCAR in C3H/3T3 cells should be conﬁrmed
at the protein level to distinguish between surface and cyto-
plasmic mCAR expression. Unfortunately, the frequently
used monoclonal antibody RmcB, which recognizes hCAR,
does not react with mCAR and a speciﬁc antibody for the
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Fig. 3. mRNA expression for mouse CAR (mCAR) and b-actin.
RNA-extracts of conﬂuent CHO-K1, CHO-mCAR-EGFP and C3H/
3T3 cells were used for the evaluation of mCAR mRNA expression by
RT-PCR. mCAR cDNA was (a) ampliﬁed in a standard PCR after
which the PCR products were visualised by ethidium bromide staining
on agarose gel or (b) subjected to real-time PCR analysis for the
quantiﬁcation of mCAR mRNA expression. Determination of b-actin
expression was included to normalize the results for the diﬀerent cell
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able [26,24].3.3. Binding of Ad2 and Ad3 to CHO-mCAR-EGFP cells
To test whether the CHO-mCAR-EGFP cells showed in-
creased expression of functional mCAR protein relative to
wild type CHO-K1 cells, a binding assay was set up with
Ad2 and Ad3. Since A549 cells are permissive for Ad2
and Ad3, these cells were used as a positive control. A
real-time PCR assay was developed to measure virus attach-
ment. Besides the advantage of its non-radioactive approach,
this real-time PCR assay oﬀers the possibility to directly
quantify the precise number of attached virus particles.
Binding eﬃciency was deﬁned as the percentage of attached
virus particles relative to the total amount of virus particles
added. Since CHO-K1 cells do not show membrane
expression of CAR [1], they do not show marked binding
of Ad2 (Fig. 4). By comparison, the binding of Ad2increased 20-fold in the CHO-mCAR-EGFP-transfectant
cells. As similar results were obtained earlier for Ad5
binding to hCAR-transfected CHO cells [27], it is clear that
the EGFP-tag in the mCAR-EGFP fusion protein does not
alter the functionality of the mCAR receptor protein. A549
cells were only ﬁve times more eﬃcient in Ad2 binding than
CHO-K1. Ad3, a member of subgroup B adenoviruses, does
not bind to CAR [2,3], but, instead, uses the immunoregula-
tory molecules CD46, CD80 and/or CD86 as primary
attachment receptors [28,29]. Therefore, binding of Ad3 to
CHO-mCAR-EGFP cells was identical to that in wild type
CHO-K1 cells (Fig. 4). These binding experiments with
Ad2 and Ad3 demonstrate that the CHO-mCAR-
EGFP transfected cells exhibit a functional mCAR-EGFP
protein.
3.4. MAV-1 binding to CHO-mCAR-EGFP cells
A binding assay with MAV-1 showed that the presence of
mCAR-EGFP did not enhance the attachment of MAV-1,
since binding to CHO-mCAR-EGFP cells was identical to
that seen with wild type CHO-K1 cells (Fig. 4). For both cell
lines, binding eﬃciency of MAV-1 was 10%, similar to what
was seen with the mouse ﬁbroblast C3H/3T3 cells, which
served as control. Notably, these binding capacities were
comparable to those of Ad2 on A549 cells, with approxi-
mately 3000 virus particles attached per cell. These ﬁndings
implicate that attachment of MAV-1 is independent of
mCAR.
3.5. Eﬀect of Ad5 ﬁber knob on virus binding
Adenovirus binding can be blocked by competition with
puriﬁed ﬁbers, and the Ad2 and Ad5 ﬁbers are interchange-
able in CAR blocking assays [30]. Subgroup B and C adeno-
viruses recognize diﬀerent receptors and it is known that the
puriﬁed ﬁber knobs of Ad2 and Ad5 do not compete with
Ad3 [30,31]. We ﬁrst performed a competition assay with
Ad2 and Ad3 on A549 cells, pre-incubated with Ad5 ﬁber
knob (Ad5F) at 0.5, 5 or 50 lg per ml. Binding of Ad2 to
A549 was 70–90% reduced compared to the condition in
which no Ad5F was added (Fig. 5). No inhibitory eﬀect of
Ad5F on the binding of Ad3 to A549 was noted. In order
to determine whether MAV-1 binding was sensitive to
Ad5F, attachment of MAV-1 to A549 or C3H/3T3 cells
was determined in the presence of 0.5, 5 or 50 lg per ml of
Ad5F. Addition of Ad5F had no inhibitory eﬀect on MAV-
1 binding to neither A549 nor C3H/3T3 cells (Fig. 5),
conﬁrming that mCAR does not play a role in MAV-1
attachment.
Taken together, the studies with mCAR-EGFP transfected
CHO cells and the inhibition experiments with the Ad5 ﬁber
knob clearly demonstrate the CAR-independence of MAV-1
attachment. This conclusion is also indirectly supported by
the fact that C3H/3T3 cells, which show only weak expres-
sion of mCAR, show eﬃcient binding of MAV-1. Since
mCAR and hCAR are very similar, we anticipate that
MAV-1 binding to human cells is also independent of hCAR.
This could make MAV-1 a potential candidate for the devel-
opment of novel vectors with an extended or modiﬁed tro-
pism, thereby circumventing the paucity of CAR-expression
on various target (e.g. tumor) cells, as well as the issue of
pre-existing immunity against vectors derived from human
adenoviruses.
Fig. 4. Attachment of adenoviruses to mCAR. Conﬂuent monolayers of CHO-mCAR-EGFP, A549, C3H/3T3 or wild type CHO-K1 cells were
incubated with Ad2, Ad3 or MAV-1 for 1 h at 4 C and, after washing, subjected to DNA extraction for subsequent analysis with real-time PCR.
Binding capacities are presented as the percentage of the number of attached virus particles relative to the total amount of added virus particles.
Means (±S.E.M.) of three independent experiments are shown, each condition performed in duplicate. *, P < 0.05 and , P > 0.05 versus CHO-K1.
Fig. 5. Inhibition of adenovirus binding by Ad5 ﬁber knob (Ad5F). Conﬂuent monolayers of A549 or C3H/3T3 cells were pre-incubated with 0.5, 5
or 50 lg/ml Ad5F for 45 min at 4 C, after which Ad2, Ad3 or MAV-1 was added and incubated for 1 h at 4 C. Subsequently, non-bound ﬁber knob
and adenovirus particles were removed and cells were subjected to DNA-extraction for analysis by real-time PCR. Binding capacities are presented as
the percentage of the number of attached virus particles relative to the total amount of added virus particles, in the presence or absence of Ad5F.
Means (±S.E.M.) of two to three independent experiments are shown (each condition performed in duplicate), except for the condition marked with
§, which is from a single experiment. *, P < 0.05 and , P > 0.05 versus 0 lg/ml Ad5F.
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